MétaCan
Menu
Back to cohort
Record W4281781727 · doi:10.1155/2022/7325060

Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 Registry

2022· article· en· W4281781727 on OpenAlexaff
José Miguel Rivera‐Caravaca, Iván J. Núñez‐Gil, Gregory Y.H. Lip, Aitor Uribarri, María C. Viana‐Llamas, Adelina González, Alex F. Castro‐Mejía, Berta González, Emilio Alfonso, Juan Fortunato García Prieto, Chiara Cavallino, Bernardo Cortese, Gisela Feltes, Inmaculada Fernández‐Rozas, Jaime Signes‐Costa, Jia Huang, Marcos Garcı́a Aguado, Martino Pepe, Rodolfo Romero, Enrico Cerrato, Víctor Manuel Becerra‐Muñoz, Sergio Raposeiras‐Roubín, Francesco Santoro, Rodrigo Bagur, Luciano A. Sposato, Ibrahim El‐Battrawy, Álvaro López Masjuan, Antonio Fernández‐Ortíz, Vicente Estrada, Carlos Macaya, Francisco Marı́n

Bibliographic record

VenueInternational Journal of Clinical Practice · 2022
Typearticle
Languageen
FieldMedicine
TopicCOVID-19 Clinical Research Studies
Canadian institutionsRobarts Clinical TrialsWestern UniversityLawson Health Research InstituteLondon Health Sciences Centre
FundersEuropean Regional Development FundInstituto de Salud Carlos IIICentro de Investigación Biomédica en Red Enfermedades CardiovascularesFundación Interhospitalaria para la Investigación CardiovascularMinisterio de Asuntos Económicos y Transformación Digital, Gobierno de España
KeywordsMedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineBetacoronavirusCoronavirus InfectionsMEDLINEEmergency medicineInternal medicineVirologyOutbreak

Abstract

fetched live from OpenAlex

Background . Most evidence regarding anticoagulation and COVID‐19 refers to the hospitalization setting, but the role of oral anticoagulation (OAC) before hospital admission has not been well explored. We compared clinical outcomes and short‐term prognosis between patients with and without prior OAC therapy who were hospitalized for COVID‐19. Methods . Analysis of the whole cohort of the HOPE COVID‐19 Registry which included patients discharged (deceased or alive) after hospital admission for COVID‐19 in 9 countries. All‐cause mortality was the primary endpoint. Study outcomes were compared after adjusting variables using propensity score matching (PSM) analyses. Results . 7698 patients were suitable for the present analysis (675 (8.8%) on OAC at admission: 427 (5.6%) on VKAs and 248 (3.2%) on DOACs). After PSM, 1276 patients were analyzed (638 with OAC; 638 without OAC), without significant differences regarding the risk of thromboembolic events (OR 1.11, 95% CI 0.59–2.08). The risk of clinically relevant bleeding (OR 3.04, 95% CI 1.92–4.83), as well as the risk of mortality (HR 1.22, 95% CI 1.01–1.47; log‐rank p value = 0.041), was significantly increased in previous OAC users. Amongst patients on prior OAC only, there were no differences in the risk of clinically relevant bleeding, thromboembolic events, or mortality when comparing previous VKA or DOAC users, after PSM. Conclusion . Hospitalized COVID‐19 patients on prior OAC therapy had a higher risk of mortality and worse clinical outcomes compared to patients without prior OAC therapy, even after adjusting for comorbidities using a PSM. There were no differences in clinical outcomes in patients previously taking VKAs or DOACs. This trial is registered with NCT04334291/EUPAS34399 .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.369
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.557
Threshold uncertainty score0.636

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.369
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.152
GPT teacher head0.531
Teacher spread0.379 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueInternational Journal of Clinical PracticeSame topicCOVID-19 Clinical Research StudiesFrench-language works237,207